Cystitis

Cystitis is an infection or inflammation of the bladder, typically presenting with localized symptoms such as suprapubic pain, dysuria, frequency, urgency, and occasionally hematuria, without systemic signs of infection. It is commonly caused by bacterial pathogens, particularly Escherichia coli, and is distinct from chronic conditions like interstitial cystitis. Uncomplicated cystitis is effectively treated with bladder-concentrating antibiotics such as nitrofurantoin and oral fosfomycin. However, no prevention strategies have been scientifically proven to be effective. Treatment during pregnancy is not covered in this context.

References:

[1]. Cystitis. sciencedirect.

Cystitis (2):

Targets:	mAChR (2)

Cat. No.	Product Name	CAS No.	Purity	Chemical Structure

HY-14825A

Tarafenacin D-tartrate	1159101-48-0	99.86%
Tarafenacin (SVT-40776) (D-tartrate) is an orally active, selective M3 muscarinic receptor (M3 muscarinic receptor) antagonist with 203-fold selectivity over the M2 muscarinic receptor. Tarafenacin (D-tartrate) does not affect atrial contraction, arterial blood pressure or arterial pressure at high doses. Tarafenacin (D-tartrate) can be used in the research of overactive bladder.

HY-14825

Tarafenacin	385367-47-5
Tarafenacin (SVT-40776) is an orally active, selective M3 muscarinic receptor (M3 muscarinic receptor) antagonist with 203-fold selectivity over the M2 muscarinic receptor. Tarafenacin does not affect atrial contraction, arterial blood pressure or arterial pressure at high doses. Tarafenacin can be used in the research of overactive bladder.

Name
Email *

	Sorry, but the email address you supplied was invalid.